Inhaled Liposomal Ciprofloxacin Protects against a Lethal Infection in a Murine Model of Pneumonic Plague

Inhalation of Yersinia pestis can lead to pneumonic plague, which without treatment is inevitably fatal. Two novel formulations of liposome-encapsulated ciprofloxacin, ‘ciprofloxacin for inhalation’ (CFI, Lipoquin(®)) and ‘dual release ciprofloxacin for inhalation’ (DRCFI, Pulmaquin(®)) containing C...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamblin, Karleigh A., Armstrong, Stuart J., Barnes, Kay B., Davies, Carwyn, Laws, Thomas, Blanchard, James D., Harding, Sarah V., Atkins, Helen S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292416/
https://www.ncbi.nlm.nih.gov/pubmed/28220110
http://dx.doi.org/10.3389/fmicb.2017.00091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292416/
https://www.ncbi.nlm.nih.gov/pubmed/28220110
http://dx.doi.org/10.3389/fmicb.2017.00091

Ejemplares similares